U.S. Tech Hardware Stock News

If you are wondering whether Sinclair's current share price fairly reflects its underlying worth, you are not alone. Many investors are asking the same question as the stock trades around US$14.06. The share price has seen mixed returns, with a 6.0% decline over the last 7 days and a 6.6% decline over 30 days, along with a 2.9% gain over 1 year and a 6.3% gain over 3 years, while the 5 year return sits at a 46.3% decline. Recent headlines around Sinclair have focused on its position in the...

Apple Hospitality REIT (NYSE:APLE) announced the resignation of Board member Kristian Gathright after seven years of service. During 2025, the company shifted 13 Marriott managed hotels to third party franchises and completed the sale of seven hotels. Apple Hospitality REIT also initiated share repurchases and continued investing in property development during 2025. Apple Hospitality REIT, trading at $12.15, has mixed longer term share performance, with a 5 year return of 13.3%, a 1 year...

If you are wondering whether Xylem's current share price lines up with its underlying value, this article walks through the key numbers so you can judge for yourself. Xylem recently closed at US$128.13, with returns of 1.3% over 1 year, 29.4% over 3 years and 33.3% over 5 years. The stock has seen a 9.3% decline over 30 days and a flat 7 day move. Recent headlines around Xylem have focused on its role in the capital goods sector and investor interest in water technology companies. This helps...

Ziff Davis (ZD) has wrapped up FY 2025 with fourth quarter revenue of US$406.7 million and basic EPS of US$0.01, setting a mixed tone for the year’s finish. The company has seen revenue move from US$412.8 million and EPS of US$1.51 in Q4 FY 2024 to US$406.7 million and EPS of US$0.01 in Q4 FY 2025. Trailing 12 month revenue sits at US$1.5 billion with EPS of US$1.16. With net margin over the last year at 3.3% and a large one off loss weighing on reported profitability, investors are likely to...

If you are trying to work out whether OneStream is attractively priced or not, this article will walk through what its current valuation might be telling you. With the share price at US$23.48 and returns of 0.4% over 7 days, a 0.6% decline over 30 days and 32.5% year to date, OneStream has caught the eye of investors who are watching how sentiment could be shifting. Recent coverage has focused on OneStream as part of the broader conversation around software names, which helps explain why...

If you are looking at Lincoln Electric Holdings and wondering whether the current share price still offers value, you are not alone. A closer look at how it is priced can be helpful before you make any big decisions. The stock last closed at US$284.98, with returns of 10.2% over 30 days, 16.9% year to date, 39.1% over 1 year, 77.0% over 3 years, and 157.2% over 5 years. This naturally raises questions about how much of the story is already reflected in the price. Recent news around Lincoln...

Enova International (NYSE:ENVA) announces an agreement to acquire Grasshopper Bancorp, Inc. The transaction adds a digital bank platform to Enova's existing fintech and online lending operations. The deal is expected to expand Enova's reach with small business and digitally focused customers. For investors, this move connects Enova International's consumer and small business lending focus with a full digital banking platform at Grasshopper Bancorp, Inc. NYSE:ENVA is already rooted in online...

If you are wondering whether Coca-Cola Consolidated is still reasonably priced after a strong run, this article will walk through what the current share price might be implying about its value. The stock recently closed at US$195.20, with returns of 17.5% over 7 days, 30.0% over 30 days, 30.3% year to date and 41.2% over 1 year. The 3 year return is 262.7% and the 5 year return is roughly 7x the earlier level. Recent news around Coca-Cola Consolidated has largely focused on its position...

FDA milestones put Larimar Therapeutics (LRMR) and nomlabofusp in sharper focus Larimar Therapeutics (LRMR) is back on investors’ radar after the FDA granted Breakthrough Therapy Designation to its Friedreich's ataxia candidate nomlabofusp and signaled openness to a surrogate endpoint supporting a potential accelerated approval filing. See our latest analysis for Larimar Therapeutics. The FDA update has arrived alongside a sharp pickup in momentum, with a 1 day share price return of 31.32%...

If you are wondering whether Veracyte shares are attractively priced right now, you are not alone. This article is built to help you think clearly about what you are paying for. The stock closed at US$35.69, with returns of a 0.9% decline over 7 days, a 15.6% decline over 30 days, a 15.8% decline year to date and a 6.7% decline over 1 year, while the 3 year return sits at 45.0% and the 5 year return at a 42.6% decline. Recent news coverage has focused on Veracyte's position in genomic...

If you are wondering whether Allison Transmission Holdings is still fairly priced after its strong run, this article will walk through what the current share price might be implying about value. The stock last closed at US$121.99, with returns of 3.9% over 7 days, 11.3% over 30 days, 23.3% year to date and 24.2% over the past year. The 3 year and 5 year returns are very large at about 1.7x and 2.3x respectively. Recent coverage has focused on Allison Transmission Holdings as a long term...

A law firm has opened an investigation into McKesson's Board of Directors over potential breaches of fiduciary duty tied to a 2013 stock incentive plan. The review focuses on the Board's recommendation that shareholders approve issuing a substantial number of additional shares and the possible dilutive effect on existing holders. The inquiry centers on whether the Board acted in the best interests of shareholders when it supported the expanded stock issuance. For investors in McKesson,...

Iovance Biotherapeutics (IOVA) closed out FY 2025 with fourth quarter revenue of US$86.8 million and a basic EPS loss of US$0.18, alongside a quarterly net loss of US$71.9 million. The company has seen quarterly revenue move from US$73.7 million in Q4 2024 to US$86.8 million in Q4 2025, while basic EPS shifted from a loss of US$0.26 to a loss of US$0.18 over the same period, setting up a results season where investors are weighing growing sales against ongoing losses. With trailing twelve...

Rackspace Technology (RXT) has quickly moved onto many investors’ radars after announcing a partnership with Palantir Technologies that positions the company as a managed services provider for Palantir’s data and AI platforms. See our latest analysis for Rackspace Technology. The Palantir announcement has coincided with a sharp shift in sentiment, with a 7 day share price return of 248.45% and a 30 day share price return of 82.07%. However, the 1 year total shareholder return of 43.41% and 5...

In February 2026, Clean Energy Fuels reported fourth-quarter 2025 results showing revenue of US$112.32 million and a wider net loss of US$43.00 million, alongside guidance for a 2026 net loss attributable to the company of US$71.00 million to US$66.00 million, excluding unrealized contract impacts and estimated US$47.00 million of Amazon warrant charges. The company also flagged that swings in diesel and natural gas markets, plus variations in Amazon warrant vesting, could materially alter...

If you are wondering whether Venture Global's share price is offering value right now, you are not alone. This article is set up to help you frame that question clearly. The stock last closed at US$9.35, with a 6.6% gain over the past 7 days, a 5.4% decline over 30 days, a 32.8% return year to date, and a 33.3% decline over the last year. Recent coverage around Venture Global has focused on its position in the US energy market and ongoing interest in liquefied natural gas projects, which...

Lindsay (NYSE:LNN) has introduced two new safety products, the Road Runner Truck-Mounted Attenuator and the AlphaGuard Channelizing Device. The products expand the company’s roadway and work zone safety lineup, targeting construction and traffic management applications. Both launches focus on work zone protection, operational efficiency, and evolving infrastructure management needs. Lindsay, trading at $135.74, is building on its position in roadway and infrastructure safety with these new...

ImmunityBio FY 2025 earnings snapshot ImmunityBio (IBRX) has reported its FY 2025 results with Q4 revenue of US$38.3 million and a basic EPS loss of US$0.06, alongside net income loss excluding extra items of US$61.9 million. This puts the focus squarely on how quickly the business can scale to cover its cost base. The company has seen quarterly revenue move from US$7.6 million in Q4 2024 to US$16.5 million in Q1 2025, US$26.4 million in Q2 2025, US$32.1 million in Q3 2025 and US$38.3 million...

If you are wondering whether Invitation Homes is starting to look like value at its current share price, this article will walk through what the numbers actually say about that question. The stock closed at US$25.67, with returns of 5.4% decline over 7 days, 5.6% decline over 30 days, 7.4% decline year to date, 16.9% decline over 1 year, 9.0% decline over 3 years and 1.6% gain over 5 years. These figures may have some investors reassessing both the potential upside and the risks. Recent...

If you are wondering whether Ionis Pharmaceuticals' share price still reflects good value after a strong run, this article walks through what the current market price might be implying. The stock most recently closed at US$85.45, with returns of 5.0% over 7 days, 6.4% over 30 days, 7.3% year to date, 168.3% over 1 year, 138.0% over 3 years and 54.5% over 5 years, which naturally raises questions about future risk and reward. Recent news flow around Ionis has continued to focus on its role in...

If you are wondering whether PicS is attractively priced at its recent levels, this article will walk through what the current numbers are really saying about the stock. The share price recently closed at US$16.81, with a 7 day return of 27.4% and a year to date return of an 11.5% decline. This has caught the attention of investors who are considering the balance between growth potential and risk. Recent news coverage around PicS has focused on its positioning within the diversified...

Pamela Seymon and former CEO Sharmistha Dubey plan to leave Match Group's Board at the 2026 Annual Meeting. The departures will change the board composition at NasdaqGS:MTCH and affect its governance structure. Investors are watching for how these board changes may influence oversight and long term company direction. Match Group, the parent of several online dating platforms, sits at the center of how people form relationships through digital services. As user behavior, regulation, and...

Martin Marietta Materials (NYSE:MLM) has closed an asset exchange with Quikrete Holdings involving aggregates, cement, ready-mix, and nonoperating land assets. The deal shifts NYSE:MLM further toward an aggregates-led product mix and adds cash to the balance sheet. The transaction covers operations in multiple regions and is described by the company as a key part of its SOAR 2025 plan. Management frames the exchange as a step toward greater earnings durability, added financial flexibility,...

If you are wondering whether Five9 is now a bargain or still carries more risk than reward, looking closely at how its current share price stacks up against different valuation measures can help clarify the picture. The stock last closed at US$17.83, with a 9.2% return over the past week, but returns of 2.7% decline over 30 days, 5.2% decline year to date, and 54.0% decline over the past year, and 73.0% and 90.5% declines over the past 3 and 5 years respectively, highlight how sentiment has...